Torrent Pharmaceuticals Limited
TORNTPHARM
Pozycja w akcjach
#1202
Torrent Pharmaceuticals Limited operates as a global pharmaceutical entity,... Torrent Pharmaceuticals Limited operates as a global pharmaceutical entity, managing the entire process from the discovery and development of generic drug formulations to their production and distribution. Its commercial activities extend across key markets such as India, the United States, Germany, and Brazil, alongside various other international territories. The company boasts a broad product catalog, offering treatments for a wide array of medical conditions. This includes therapies for cardiovascular diseases, central nervous system disorders, gastrointestinal issues, women's health concerns, diabetes, pain management, gynecological ailments, oncology, and anti-infective medications. Additionally, Torrent Pharma supplies essential vitamins, minerals, and other nutritional supplements. Beyond its proprietary offerings, the firm also provides contract manufacturing services to other companies. During the COVID-19 pandemic, it demonstrated its commitment by securing licensing agreements for crucial treatments like Baricitinib, Molnupiravir, and Paxlovid. Established in 1959, the company originally operated under the name Trinity Laboratories before officially becoming Torrent Pharmaceuticals Limited in 1971. Its corporate headquarters are located in Ahmedabad, India. Ultimately, Torrent Pharmaceuticals Limited functions as a subsidiary of Torrent Investments Private Limited.
Cena akcji
$50.34
Kapitalizacja rynkowa
$19.15B
Zmiana (1 dzień)
-0.07%
Zmiana (1 rok)
23.64%
Kraj
IN
Handel Torrent Pharmaceuticals Limited (TORNTPHARM)
Kategoria
Healthcare
Marża operacyjna dla Torrent Pharmaceuticals Limited (TORNTPHARM)
Marża operacyjna na dzień October 2026 TTM: 23.45%
Według najnowszych raportów finansowych i ceny akcji Torrent Pharmaceuticals Limited, bieżąca marża operacyjna (TTM) wynosi 23.45%. Na koniec 2024 wynosiła 51.25%.
Historia marży operacyjnej dla Torrent Pharmaceuticals Limited od 2005 do 2026
Marża operacyjna na koniec każdego roku
| Rok | Marża operacyjna | Zmień |
|---|---|---|
| 2026 (TTM) | 23.45% | -54.14% |
| 2025 | 51.13% | -0.23% |
| 2024 | 51.25% | 5.71% |
| 2023 | 48.48% | 3.08% |
| 2022 | 47.03% | -3.77% |
| 2021 | 48.87% | 1.14% |
| 2020 | 48.32% | 5.59% |
| 2019 | 45.76% | 1.55% |
| 2018 | 45.06% | -0.73% |
| 2017 | 45.39% | -24.75% |
| 2016 | 60.32% | 30.65% |
| 2015 | 46.17% | 0.00% |
| 2014 | 46.17% | 127.21% |
| 2013 | 20.32% | 17.73% |
| 2012 | 17.26% | 3.23% |
| 2011 | 16.72% | -11.91% |
| 2010 | 18.98% | 40.70% |
| 2009 | 13.49% | 8.35% |
| 2008 | 12.45% | 29.15% |
| 2007 | 9.64% | 12.22% |
| 2006 | 8.59% | -15.62% |
| 2005 | 10.18% | 0.00% |
Marża operacyjna dla podobnych firm lub konkurentów
| Firma | Marża operacyjna | Różnica w marży operacyjnej | Kraj |
|---|---|---|---|
| 0.00% | - |
DE
|
|
| 0.00% | - |
DE
|
|
| 0.00% | - |
JP
|
|
| 0.00% | - |
CH
|
|
| 22.93% | -99.02% |
IN
|
Czym jest marża operacyjna firmy?
Marża operacyjna to kluczowy wskaźnik do oceny rentowności firmy. Wyższe marże operacyjne są zazwyczaj korzystniejsze, ponieważ pokazują, że firma może sprzedawać swoje produkty lub usługi znacznie drożej niż koszty ich produkcji. Oblicza się ją, dzieląc zysk firmy przez jej przychody.